Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...
As the Trump administration issued an abrupt pause to federal financial assistance, the move threatened billions in grants ...
A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to ...
The Trump Administration’s abrupt cancellation of National Institutes of Health meetings and grant reviews has sparked ...
Pharmaron, a Chinese biotech firm, is currently using hundreds of thousands of taxpayer dollars to test pharmaceuticals on up ...
Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health ...
Scientists at the National Institutes of Health have been told the communications pause announced by the Trump Administration ...
President Trump has placed an indefinite suspension on research grant reviews and travel at the National Institutes of Health ...
Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...
Major academic research institutions and medical schools in the Philadelphia region are allotted $1.7 billion in NIH funding.
"The government cannot be a welfare program for everybody doing low quality, low credibility, irreproducible, low value of ...
The change in administration in Washington, D.C., is affecting the distribution of federal funds to institutions in North ...